PGT identifies high value discovery-stage opportunities that will be first in class and/or best in class assets via research collaborations with world-leading institutions in the United States, Europe and Asia.
About Pacific GeneTech
Pacific GeneTech develops and commercializes next-generation vaccines which target areas of high unmet need in livestock animal health and food safety using a proprietary platform, Aegis, to protect across pathogen strains. The vaccines are complemented by Hercules Adjuvant System, an exclusive universal adjuvant proven to boost efficacy. The company identifies high value discovery-stage opportunities through research collaborations with leading institutions and in-licenses additional novel vaccine technologies to take them to commercialization through licensing and partnership with global and regional partners.